ADOC — Adocia SA Share Price
0.000.00%
Last trade - 00:00- €82.13m
- €98.60m
- €11.45m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 2.01 | ||
| PEG Ratio (f) | 0.05 | ||
| EPS Growth (f) | 70.93% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 14.35 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -263.83% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 47.39 | 2.14 | 0.84 | 1.44 | 11.45 | 35 | 49.5 | -10.08% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | +70.93 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Adocia SA is a clinical-stage biotechnology company based in France. The Company specializes in the development of formulations of already-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary technological platform BioChaperone is designed to enhance the effectiveness and/or safety of therapeutic proteins while making them easier for patients to use. The Company’s clinical pipeline includes four novel insulin formulations for the treatment of diabetes: two formulations of insulin analog lispro (BioChaperone Lispro U100 and U200), a combination of basal insulin glargine and insulin lispro (BioChaperone Combo), and a combination of prandial insulin with amylin analog pramlintide: M1Pram. Its preclinical pipeline includes three products BioChaperone LisPram, BioChaperone Glargine GLP-1 and BioChaperone Glucagon GLP1.
Directors
- Gerard Soula CHM (76)
- Olivier Soula DCE (50)
- Valerie Danaguezian CFO
- Remi Soula EXB
- Laurent Arthaud DRC (58)
- Olivier Martinez DRC (49)
- Stephane Boissel IND
- Kathy Bowdish IND
- Claudia Mitchell IND
- Ekaterina Smirnyagina IND (53)
- Dominique Takizawa IND (64)
- Last Annual
- December 31st, 2022
- Last Interim
- June 30th, 2023
- Incorporated
- January 1st, 2006
- Public Since
- February 20th, 2012
- No. of Employees
- 100
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Euronext - Paris
- Shares in Issue
- 9,719,770
- Address
- 115 avenue Lacassagne, LYON, 69003
- Web
- https://www.adocia.com/
- Phone
- +33 472610610
- Auditors
- Ernst & Young et Autres
Upcoming Events for ADOC
Adocia SA Annual Shareholders Meeting
Q1 2024 Adocia SA Corporate Sales Release
Adocia SA at Equity Forum German Spring Conference
Q2 2024 Adocia SA Corporate Sales Release
Half Year 2024 Adocia SA Earnings Release
Similar to ADOC
Abionyx Pharma SA
Euronext - Paris
Abivax SA
Euronext - Paris
Acticor Biotech SA
Euronext - Paris
Biophytis SA
Euronext - Paris
Cellectis SA
Euronext - Paris
FAQ
What is the Adocia SA share price?
As of Today at 19:00 UTC, shares in Adocia SA are trading at €8.45. This share price information is delayed by 15 minutes.
How has the Adocia SA share price performed this year?
Shares in Adocia SA last closed at €8.45 and the price had moved by +186.93% over the past 365 days. In terms of relative price strength the Adocia SA share price has outperformed the FTSE Global All Cap Index by +169.37% over the past year.
What are the analyst and broker recommendations for Adocia SA?
The overall consensus recommendation for Adocia SA is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Adocia SA dividend yield?
Adocia SA does not currently pay a dividend.
Does Adocia SA pay a dividend?
Adocia SA does not currently pay a dividend.
When does Adocia SA next pay dividends?
Adocia SA does not currently pay a dividend.
How do I buy Adocia SA shares?
To buy shares in Adocia SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Adocia SA?
As of the previous close price of €8.45, shares in Adocia SA had a market capitalisation of €82.13m.
Where are Adocia SA shares listed?
Here are the trading details for Adocia SA:
- Country of listing: France
- Exchange: PAR
- Ticker Symbol: ADOC
What kind of share is Adocia SA?
Based on an overall assessment of its quality, value and momentum Adocia SA is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Adocia SA share price forecast for 2024?
The analyst consensus target price for shares in Adocia SA is €10.80. That is 27.81% above the last closing price of €8.45.
Analysts covering Adocia SA currently have a consensus Earnings Per Share (EPS) forecast of €2.46 for the next financial year.
What is the trend in the Adocia SA share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Adocia SA. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +3.82%.
As of the last closing price of €8.45, shares in Adocia SA were trading -3.16% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Adocia SA PE Ratio?
The Adocia SA PE ratio based on its reported earnings over the past 12 months is 2.01. The shares last closed at €8.45.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Adocia SA?
Adocia SA's management team is headed by:
- Gerard Soula - CHM
- Olivier Soula - DCE
- Valerie Danaguezian - CFO
- Remi Soula - EXB
- Laurent Arthaud - DRC
- Olivier Martinez - DRC
- Stephane Boissel - IND
- Kathy Bowdish - IND
- Claudia Mitchell - IND
- Ekaterina Smirnyagina - IND
- Dominique Takizawa - IND